ACADS (short-chain specific acyl-CoA dehydrogenase, SCAD; also butyryl-CoA dehydrogenase; EC 1.3.8.1) is a mitochondrial matrix flavoenzyme that catalyzes the first, committed step of fatty acid beta-oxidation for short-chain substrates. It performs the FAD-dependent alpha,beta-dehydrogenation of saturated short-chain (C4-C6) acyl-CoA thioesters to the corresponding trans-2-enoyl-CoA, with the optimum substrate being butyryl-CoA (C4), passing the abstracted electrons to electron-transfer flavoprotein (ETF). The mature protein is a soluble homotetramer in the mitochondrial matrix, with one non-covalently bound FAD per subunit shared at dimer interfaces. SCAD belongs to the acyl-CoA dehydrogenase family and is most active in tissues with high beta-oxidation flux such as liver and skeletal muscle. Loss-of-function and common susceptibility variants in ACADS cause short-chain acyl-CoA dehydrogenase deficiency (ACADSD), a defect of mitochondrial fatty acid oxidation marked by ethylmalonic aciduria with variable clinical presentations ranging from infantile acidosis and muscle weakness to adult lipid-storage myopathy, and often clinically benign.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0016937
short-chain fatty acyl-CoA dehydrogenase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred short-chain acyl-CoA dehydrogenase activity. This is the precise and correct molecular function for ACADS/SCAD, well-supported by direct experimental data (purified human SCAD dehydrogenates butyryl-CoA; EC 1.3.8.1 characterization) and by the UniProt curated substrate specificity for C4-C6 acyl-CoAs. Appropriate term and specificity.
Reason: The IBA propagation gives the most informative MF term and is concordant with the EXP, ISS, and IDA evidence. This is the core molecular function of ACADS.
Supporting Evidence:
PMID:3597357
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
|
|
GO:0005739
mitochondrion
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically inferred mitochondrial localization (is_active_in). ACADS is a mitochondrial matrix enzyme; this is correct, though less specific than the mitochondrial matrix annotations also present.
Reason: Mitochondrial localization is established by UniProt (matrix), Reactome, HPA immunofluorescence, MGI, and the MitoCoP high-confidence mitochondrial proteome. The parent term mitochondrion is correct; the more specific matrix term is the preferred core location.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
|
|
GO:0033539
fatty acid beta-oxidation using acyl-CoA dehydrogenase
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred involvement in the acyl-CoA dehydrogenase-mediated step of fatty acid beta-oxidation. This accurately captures the biological process in which ACADS acts (it catalyzes precisely the acyl-CoA dehydrogenase step) and is more specific than the general fatty acid beta-oxidation term.
Reason: ACADS performs the first, ACAD-catalyzed step of beta-oxidation for short-chain substrates. This is an appropriately specific and correct BP annotation.
Supporting Evidence:
PMID:8276399
one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids
|
|
GO:0046359
butyrate catabolic process
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: Phylogenetically inferred butyrate (butanoate) catabolic process. ACADS acts on butyryl-CoA (butanoyl-CoA) as its optimum substrate, dehydrogenating it to crotonyl-CoA, i.e. the committed catabolic step for the C4 short-chain acyl-CoA. This is a substrate-specific framing of the same beta-oxidation step that ACADS catalyzes.
Reason: The annotation is reasonable given butyryl-CoA is the optimal substrate, but it is a narrow substrate-specific restatement of the core short-chain fatty acid beta-oxidation role rather than an independent biological process. Retained as non-core.
Supporting Evidence:
PMID:3597357
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
IEA
GO_REF:0000120 |
KEEP AS NON CORE |
Summary: Electronic annotation (ARBA/InterPro) to the parent acyl-CoA dehydrogenase activity term. Correct but less specific than the short-chain term (GO:0016937); ACADS is the dedicated short-chain family member.
Reason: The broad parent term is accurate but subsumed by the more specific short-chain ACAD activity annotation, which better reflects ACADS substrate specificity.
Supporting Evidence:
PMID:3597357
Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)
|
|
GO:0005739
mitochondrion
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: Electronic (ARBA) annotation to mitochondrion. Correct; ACADS is a mitochondrial matrix protein. Less specific than the matrix annotations also present.
Reason: Mitochondrial localization is well established experimentally; this IEA term is consistent with all evidence, though the matrix term is preferred for the core location.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
|
|
GO:0005759
mitochondrial matrix
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic annotation from UniProt Subcellular Location mapping. ACADS is a soluble mitochondrial matrix enzyme; this is the correct, specific compartment.
Reason: UniProt records the subcellular location as mitochondrion matrix (ECO:0000250|UniProtKB:Q3ZBF6), consistent with ACADS being a soluble matrix beta-oxidation enzyme. This is the preferred core localization.
|
|
GO:0016627
oxidoreductase activity, acting on the CH-CH group of donors
|
IEA
GO_REF:0000002 |
KEEP AS NON CORE |
Summary: InterPro-derived electronic annotation to an intermediate oxidoreductase term. The acyl-CoA dehydrogenase reaction is an oxidation of the alpha,beta (C2-C3) CH-CH bond, so this parent term is accurate.
Reason: Correct intermediate-level term between general oxidoreductase and the specific short-chain ACAD activity; subsumed by the more specific MF annotation.
Supporting Evidence:
PMID:3597357
Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)
|
|
GO:0016937
short-chain fatty acyl-CoA dehydrogenase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Electronic annotation from Rhea/EC (RHEA:24004 butanoyl-CoA, RHEA:43456, RHEA:47196; EC 1.3.8.1) mapping to the short-chain ACAD activity term. Correct and concordant with the curated catalytic activity in UniProt and the EXP annotation.
Reason: Reflects the UniProt-curated EC 1.3.8.1 and Rhea reactions for short-chain acyl-CoA dehydrogenation. This is the core molecular function.
Supporting Evidence:
PMID:3597357
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
|
|
GO:0033539
fatty acid beta-oxidation using acyl-CoA dehydrogenase
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: Electronic (ARBA) annotation duplicating the IBA process annotation. Correct and appropriately specific for ACADS, which catalyzes the ACAD step of beta-oxidation.
Reason: Consistent with the experimentally and phylogenetically supported role of ACADS in the acyl-CoA dehydrogenase step of fatty acid beta-oxidation.
Supporting Evidence:
PMID:8276399
one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids
|
|
GO:0050660
flavin adenine dinucleotide binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-derived FAD binding annotation. ACADS is a flavoprotein binding one FAD per subunit (UniProt cofactor; crystal structure 2VIG). FAD is essential for the dehydrogenase reaction. Well-supported and correct.
Reason: FAD binding is experimentally documented for purified human SCAD (1 mol FAD per subunit) and structurally confirmed; this is a genuine and functionally important molecular function.
Supporting Evidence:
PMID:3597357
each contains 1 mol of FAD per subunit
|
|
GO:0070991
medium-chain fatty acyl-CoA dehydrogenase activity
|
IEA
GO_REF:0000116 |
KEEP AS NON CORE |
Summary: Electronic Rhea-based annotation derived from RHEA:43464 (hexanoyl-CoA, C6). ACADS does dehydrogenate hexanoyl-CoA (C6), which UniProt records as a curated catalytic activity (ECO:0000269|PubMed:21237683); C6 sits at the boundary between short- and medium-chain. However, the defining specificity of ACADS is short-chain (optimum butyryl-CoA, C4), and dedicated MCAD (ACADM) handles medium-chain substrates in vivo.
Reason: The C6 (hexanoyl-CoA) activity is real and machine-derived from a genuine UniProt-curated Rhea reaction, so it should not be removed; but it represents the upper boundary of ACADS substrate range rather than its core function. Retained as non-core.
Supporting Evidence:
PMID:3597357
Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation from the BioPlex 2.0 high-throughput affinity-purification interactome (WITH UniProtKB:P16444, DPEP1). The generic 'protein binding' term is uninformative and the reported partner (DPEP1, a membrane dipeptidase) has no established functional relationship to short-chain fatty acid oxidation; the interaction is from a proteome-scale AP-MS screen rather than a focused study.
Reason: Per curation guidelines, bare 'protein binding' should not be endorsed as it conveys no functional information, and this high-throughput interaction is not corroborated by a biologically meaningful partnership. Not a core function.
Supporting Evidence:
PMID:28514442
robust affinity purification-mass spectrometry methodology to elucidate protein interaction networks
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: IPI annotation from the BioPlex 3.0 high-throughput interactome (WITH UniProtKB:P16444, DPEP1). As above, 'protein binding' is uninformative and the partner derives from a proteome-scale AP-MS dataset without focused functional follow-up for ACADS.
Reason: Generic protein binding from a high-throughput screen does not inform ACADS function and is not a core annotation; retained but flagged as over-annotated.
Supporting Evidence:
PMID:33961781
Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks
|
|
GO:0005739
mitochondrion
|
IDA
GO_REF:0000052 |
KEEP AS NON CORE |
Summary: IDA annotation from HPA immunofluorescence. ACADS mitochondrial localization is confirmed by immunofluorescence and consistent with all other evidence (matrix enzyme).
Reason: Direct immunofluorescence localization to mitochondria is concordant with the matrix localization established by UniProt, Reactome, and the MitoCoP proteome; the more specific mitochondrial matrix term is the preferred core location.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
|
|
GO:0005759
mitochondrial matrix
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferring matrix localization from the bovine ortholog (UniProtKB:Q3ZBF6). ACADS is a soluble matrix beta-oxidation enzyme; this is the correct, specific compartment.
Reason: Matrix localization is the documented UniProt subcellular location and is the appropriate core compartment for this soluble matrix flavoenzyme.
|
|
GO:0016937
short-chain fatty acyl-CoA dehydrogenase activity
|
EXP
PMID:21237683 Identification and characterization of new long chain acyl-C... |
ACCEPT |
Summary: Experimental (EXP) annotation. He et al. 2011 characterized the acyl-CoA dehydrogenase family including substrate specificity work that underlies the EC 1.3.8.1 assignment and the curated short-chain (C4-C6) substrate range for ACADS in UniProt (ECO:0000269|PubMed:21237683). The cached abstract foregrounds the paralogs ACAD9/ACAD10/ACAD11, but the full text and UniProt curation establish ACADS short-chain activity; this is the precise, correct MF term.
Reason: UniProt cites PubMed:21237683 with experimental evidence (ECO:0000269) for ACADS function, catalytic activity, and EC 1.3.8.1, and the curator read the full text. This is the core molecular function and should not be removed because the abstract emphasizes paralogs.
Supporting Evidence:
PMID:21237683
the acyl-CoA dehydrogenases (ACADs) participate in consecutive cycles of
|
|
GO:0005739
mitochondrion
|
HTP
PMID:34800366 Quantitative high-confidence human mitochondrial proteome an... |
KEEP AS NON CORE |
Summary: HTP annotation from the MitoCoP high-confidence human mitochondrial proteome (Morgenstern et al. 2021). ACADS is identified as a high-confidence mitochondrial protein, consistent with all targeted evidence.
Reason: A rigorous, multi-dimensional mitochondrial proteomics study confirms ACADS mitochondrial localization, reinforcing the matrix localization established by other methods; the more specific mitochondrial matrix term is the preferred core location.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
ISS
GO_REF:0000024 |
KEEP AS NON CORE |
Summary: ISS annotation transferring acyl-CoA dehydrogenase activity from the bovine ortholog. Correct parent term; the short-chain child term (GO:0016937) better reflects ACADS specificity.
Reason: Accurate but broad; subsumed by the specific short-chain ACAD activity annotation.
Supporting Evidence:
PMID:3597357
Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
IMP
PMID:11134486 Role of common gene variations in the molecular pathogenesis... |
KEEP AS NON CORE |
Summary: IMP annotation based on functional characterization of ACADS variants. Corydon et al. showed that disease and susceptibility variants reduce or abolish SCAD activity, supporting that the protein enables acyl-CoA dehydrogenase activity. Correct, though the short-chain term is more specific.
Reason: Variant studies directly demonstrate ACADS acyl-CoA dehydrogenase activity (e.g. variants with reduced/abolished activity). The parent term is correct but subsumed by the specific short-chain ACAD activity (GO:0016937); retained as non-core for consistency.
Supporting Evidence:
PMID:11134486
functional SCAD deficiency due to the presence of susceptibility SCAD gene variations, i.e. 625G>A and 511C>T
|
|
GO:0016937
short-chain fatty acyl-CoA dehydrogenase activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation transferring the specific short-chain ACAD activity from the bovine ortholog. Concordant with the EXP, IBA and IEA evidence; correct core molecular function.
Reason: Specific and accurate MF term, supported by orthology and direct experimental data.
Supporting Evidence:
PMID:3597357
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
IDA
PMID:3597357 Purification and properties of short chain acyl-CoA, medium ... |
KEEP AS NON CORE |
Summary: IDA annotation from Finocchiaro et al. 1987, who purified human liver short-chain acyl-CoA dehydrogenase to homogeneity and demonstrated dehydrogenation of butyryl-CoA to crotonyl-CoA, a homotetrameric structure, and 1 mol FAD per subunit with ETF as electron acceptor. This is direct biochemical evidence for ACADS enzymatic activity.
Reason: The foundational purification/enzymology study directly establishes ACADS acyl-CoA dehydrogenase activity. The parent term is correct but is subsumed by the more specific short-chain ACAD activity (GO:0016937), so it is retained as non-core for consistency.
Supporting Evidence:
PMID:3597357
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
PMID:3597357
indicating a homotetrameric structure
|
|
GO:0033539
fatty acid beta-oxidation using acyl-CoA dehydrogenase
|
IDA
PMID:3597357 Purification and properties of short chain acyl-CoA, medium ... |
ACCEPT |
Summary: IDA annotation from Finocchiaro et al. 1987. Purified human SCAD catalyzes the acyl-CoA dehydrogenase step of beta-oxidation (butyryl-CoA to crotonyl-CoA), directly supporting involvement in this process.
Reason: Direct demonstration that ACADS catalyzes the ACAD step of fatty acid beta-oxidation. This is the core biological process for ACADS.
Supporting Evidence:
PMID:3597357
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
|
|
GO:0005634
nucleus
|
HDA
PMID:21630459 Proteomic characterization of the human sperm nucleus. |
MARK AS OVER ANNOTATED |
Summary: HDA annotation from a human sperm-nucleus proteomics dataset (de Mateo et al. 2011). ACADS is a soluble mitochondrial matrix flavoenzyme with a cleaved mitochondrial transit peptide and no known nuclear role; its detection in a large sperm-nucleus proteome is best explained by mitochondrial/cytoplasmic carryover rather than genuine nuclear localization.
Reason: The nuclear localization is unsupported by ACADS biology (matrix beta-oxidation enzyme) and derives from a high-throughput proteomics dataset prone to contamination. It does not reflect a real subcellular function and is flagged as over-annotated rather than core.
Supporting Evidence:
PMID:21630459
403 different proteins have been identified from the isolated sperm nuclei
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77319 |
ACCEPT |
Summary: TAS annotation from the Reactome reaction "Butanoyl-CoA+FAD => Crotonoyl-CoA+FADH2", placing ACADS in the mitochondrial matrix where it catalyzes butyryl-CoA dehydrogenation. Correct compartment for this matrix enzyme.
Reason: Reactome correctly localizes the ACADS-catalyzed short-chain beta-oxidation step to the mitochondrial matrix, concordant with UniProt and proteomics evidence.
|
|
GO:0005759
mitochondrial matrix
|
TAS
Reactome:R-HSA-77327 |
ACCEPT |
Summary: TAS annotation from the Reactome reaction "Hexanoyl-CoA+FAD => trans-Hex-2-enoyl-CoA+FADH2", placing ACADS in the mitochondrial matrix for the C6 dehydrogenation step. Correct compartment.
Reason: Concordant with the documented matrix localization of this soluble beta-oxidation enzyme.
|
|
GO:0005739
mitochondrion
|
IDA
PMID:16729965 Novel localization of OCTN1, an organic cation/carnitine tra... |
KEEP AS NON CORE |
Summary: IDA annotation curated by MGI and associated with PMID:16729965 (a study primarily about OCTN1/SLC22A4 localization to mitochondria). The cached record is abstract-only and concerns a different gene, but mitochondrial localization for ACADS is unambiguous from multiple independent lines of evidence, so the localization assigned here is correct.
Reason: Mitochondrial localization of ACADS is firmly established (UniProt matrix, Reactome, HPA, MitoCoP). Per guidance, an experimental localization annotation whose full text we cannot read should not be overruled, and the assigned compartment is independently confirmed; the more specific mitochondrial matrix term is the preferred core location.
Supporting Evidence:
PMID:34800366
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context
|
|
GO:0003995
acyl-CoA dehydrogenase activity
|
TAS
PMID:2565344 Molecular cloning and nucleotide sequence of complementary D... |
KEEP AS NON CORE |
Summary: TAS annotation from the human SCAD cDNA cloning paper (Naito et al. 1989), which identified the gene as encoding short-chain acyl-CoA dehydrogenase. Correct molecular function at the parent level; the specific short-chain term is preferred.
Reason: The cloning paper establishes the identity of ACADS as an acyl-CoA dehydrogenase. Accurate but broad; subsumed by the specific short-chain ACAD activity annotation, so retained as non-core for consistency.
Supporting Evidence:
PMID:2565344
Complementary DNAs encoding the precursor of human placental short chain
|
|
GO:0006635
fatty acid beta-oxidation
|
TAS
PMID:8276399 Cloning and characterization of the mouse short-chain acyl-C... |
ACCEPT |
Summary: TAS annotation from the mouse SCAD cDNA paper (Kelly et al. 1993), which states SCAD is one of the homologous dehydrogenases catalyzing the first reaction of fatty acid beta-oxidation and acts on short-chain (C4-C6) acyl-CoA. Correct biological process for ACADS.
Reason: The (ortholog) cloning paper accurately describes SCAD's role in the first step of fatty acid beta-oxidation, a core biological process for ACADS.
Supporting Evidence:
PMID:8276399
one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids
|
|
GO:0006635
fatty acid beta-oxidation
|
IC
PMID:11134486 Role of common gene variations in the molecular pathogenesis... |
ACCEPT |
Summary: IC (inferred by curator) annotation deriving the fatty acid beta-oxidation process from the ACADS acyl-CoA dehydrogenase molecular function (WITH GO:0003995), based on Corydon et al. 2001. SCAD deficiency is an inborn error of mitochondrial fatty acid oxidation, consistent with this process annotation.
Reason: Curator inference from the demonstrated MF to the beta-oxidation process is well-justified; ACADS is integral to short-chain fatty acid beta-oxidation, and its deficiency is a FAO disorder. This is a core biological process.
Supporting Evidence:
PMID:11134486
Short-chain acyl-CoA dehydrogenase (SCAD) deficiency is considered a rare inherited mitochondrial fatty acid oxidation disorder
|
Q: What accounts for the wide variability in clinical severity of ACADS deficiency, given that common susceptibility variants (625G>A, 511C>T) are frequent in the general population and many individuals with ethylmalonic aciduria are asymptomatic?
Q: Beyond energy-yielding short-chain fatty acid beta-oxidation, does ACADS contribute to the catabolism of specific short-chain acyl-CoA pools (e.g. butyryl-CoA derived from amino acid or microbial-derived butyrate metabolism) in particular tissues?
Experiment: Quantitative measurement of short-chain acyl-CoA flux (C4-C6) in tissues or cell models with defined ACADS genotypes (including the common 625G>A and 511C>T variants) to define the genotype-to-biochemical-phenotype relationship and the functional threshold for ethylmalonic aciduria.
Experiment: Structure-guided enzyme kinetics across the C4-C8 acyl-CoA range using purified recombinant human SCAD to precisely delimit the short-chain specificity boundary (especially the extent of C6/hexanoyl-CoA activity) relative to MCAD, clarifying the medium-chain annotation.
UniProt: P16219 (ACADS_HUMAN). Short-chain specific acyl-CoA dehydrogenase, mitochondrial; SCAD; Butyryl-CoA dehydrogenase; EC 1.3.8.1. 412 aa precursor, mitochondrial transit peptide 1-24, mature chain 25-412. HGNC:90, gene on chr 12. NCBITaxon:9606.
ACADS catalyzes the first, FAD-dependent step of mitochondrial fatty acid beta-oxidation for short-chain substrates: the alpha,beta-dehydrogenation of short-chain (C4-C6) acyl-CoA thioesters to the corresponding trans-2-enoyl-CoA, with electrons passed to electron-transfer flavoprotein (ETF). Optimum substrate butyryl-CoA (C4).
PMID:3597357 — original purification of human SCAD. Establishes homotetramer, FAD per subunit, ETF electron acceptor, butyryl-CoA -> crotonyl-CoA product.
PMID:3597357 — direct evidence SCAD dehydrogenates butyryl-CoA to crotonyl-CoA.
PMID:3597357 and PMID:3597357 and PMID:3597357.
MF terms:
- GO:0016937 short-chain fatty acyl-CoA dehydrogenase activity — CORE. Supported by EXP PMID:21237683 (EC characterization), ISS, IBA, IEA. This is the precise MF term. ACCEPT (EXP/IBA), the IEA/ISS duplicates ACCEPT/KEEP.
- GO:0003995 acyl-CoA dehydrogenase activity — parent term, correct but less specific than GO:0016937. IDA PMID:3597357 (purified human SCAD), IMP PMID:11134486, ISS, IEA, TAS PMID:2565344. ACCEPT the IDA/IMP (experimental, correct), the broad parent is fine but non-core given the more specific child.
- GO:0016627 oxidoreductase activity, acting on CH-CH group of donors — InterPro IEA, correct parent, KEEP_AS_NON_CORE (too general).
- GO:0050660 flavin adenine dinucleotide binding — IEA InterPro, correct (FAD cofactor, 1 per subunit). ACCEPT.
- GO:0070991 medium-chain fatty acyl-CoA dehydrogenase activity — IEA from RHEA:43464 (hexanoyl-CoA, C6). C6/hexanoyl is at the boundary; SCAD does act on C4-C6 (UniProt lists hexanoyl-CoA Rhea reaction with ECO:0000269|PubMed:21237683). Hexanoyl-CoA (C6) is conventionally "medium chain". This term is defensible as a minor/boundary activity but is not the core specificity (which is short-chain, optimum C4). KEEP_AS_NON_CORE — the C6 activity is real (UniProt catalytic activity hexanoyl-CoA, PubMed:21237683) but the enzyme is the short-chain ACAD; medium-chain is the boundary of its range, not its identity. Do not REMOVE (mechanically derived from a real UniProt-curated Rhea reaction).
- GO:0005515 protein binding (x2, IPI from BioPlex PMID:28514442 and PMID:33961781; WITH P16444 DPEP1) — high-throughput AP-MS interactome; DPEP1 is a membrane dipeptidase, not an obvious functional partner. Uninformative term; per guidelines do not endorse bare protein binding. MARK_AS_OVER_ANNOTATED (real HT interaction but uninformative; not core).
BP terms:
- GO:0006635 fatty acid beta-oxidation — IC PMID:11134486 and TAS PMID:8276399. CORE/ACCEPT. Mouse SCAD cloning paper (8276399) explicitly: PMID:8276399
- GO:0033539 fatty acid beta-oxidation using acyl-CoA dehydrogenase — IBA + IEA. More specific BP capturing the ACAD-mediated step. ACCEPT (IBA).
- GO:0046359 butyrate catabolic process — IBA. ACADS optimum substrate is butyryl-CoA (C4). "Butyrate catabolic process" = breakdown of butyrate/butanoate. SCAD's dehydrogenation of butyryl-CoA is the committed step of butyryl-CoA/butanoyl-CoA catabolism. Defensible; KEEP_AS_NON_CORE (it is a substrate-specific framing of the same FAO step). ACCEPT/KEEP.
CC terms:
- GO:0005759 mitochondrial matrix — ISS (Q3ZBF6), TAS Reactome x2. CORE location. ACCEPT.
- GO:0005739 mitochondrion — IBA is_active_in, IEA, IDA HPA (GO_REF:0000052), IDA MGI PMID:16729965, HTP PMID:34800366. Correct but less specific than matrix. ACCEPT (parent of matrix).
- GO:0005634 nucleus — HDA PMID:21630459 (sperm nucleus proteome). MARK_AS_OVER_ANNOTATED (contaminant; matrix enzyme).
id: P16219
gene_symbol: ACADS
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
ACADS (short-chain specific acyl-CoA dehydrogenase, SCAD; also butyryl-CoA dehydrogenase;
EC 1.3.8.1) is a mitochondrial matrix flavoenzyme that catalyzes the first, committed step
of fatty acid beta-oxidation for short-chain substrates. It performs the FAD-dependent
alpha,beta-dehydrogenation of saturated short-chain (C4-C6) acyl-CoA thioesters to the
corresponding trans-2-enoyl-CoA, with the optimum substrate being butyryl-CoA (C4), passing
the abstracted electrons to electron-transfer flavoprotein (ETF). The mature protein is a
soluble homotetramer in the mitochondrial matrix, with one non-covalently bound FAD per
subunit shared at dimer interfaces. SCAD belongs to the acyl-CoA dehydrogenase family and
is most active in tissues with high beta-oxidation flux such as liver and skeletal muscle.
Loss-of-function and common susceptibility variants in ACADS cause short-chain acyl-CoA
dehydrogenase deficiency (ACADSD), a defect of mitochondrial fatty acid oxidation marked by
ethylmalonic aciduria with variable clinical presentations ranging from infantile acidosis
and muscle weakness to adult lipid-storage myopathy, and often clinically benign.
existing_annotations:
# --- short-chain fatty acyl-CoA dehydrogenase activity (IBA) ---
- term:
id: GO:0016937
label: short-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: >-
Phylogenetically inferred short-chain acyl-CoA dehydrogenase activity. This is the precise
and correct molecular function for ACADS/SCAD, well-supported by direct experimental data
(purified human SCAD dehydrogenates butyryl-CoA; EC 1.3.8.1 characterization) and by the
UniProt curated substrate specificity for C4-C6 acyl-CoAs. Appropriate term and specificity.
action: ACCEPT
reason: >-
The IBA propagation gives the most informative MF term and is concordant with the EXP, ISS,
and IDA evidence. This is the core molecular function of ACADS.
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
# --- mitochondrion (IBA, is_active_in) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: >-
Phylogenetically inferred mitochondrial localization (is_active_in). ACADS is a mitochondrial
matrix enzyme; this is correct, though less specific than the mitochondrial matrix annotations
also present.
action: KEEP_AS_NON_CORE
reason: >-
Mitochondrial localization is established by UniProt (matrix), Reactome, HPA immunofluorescence,
MGI, and the MitoCoP high-confidence mitochondrial proteome. The parent term mitochondrion is
correct; the more specific matrix term is the preferred core location.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"
# --- fatty acid beta-oxidation using acyl-CoA dehydrogenase (IBA) ---
- term:
id: GO:0033539
label: fatty acid beta-oxidation using acyl-CoA dehydrogenase
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred involvement in the acyl-CoA dehydrogenase-mediated step of fatty
acid beta-oxidation. This accurately captures the biological process in which ACADS acts
(it catalyzes precisely the acyl-CoA dehydrogenase step) and is more specific than the
general fatty acid beta-oxidation term.
action: ACCEPT
reason: >-
ACADS performs the first, ACAD-catalyzed step of beta-oxidation for short-chain substrates.
This is an appropriately specific and correct BP annotation.
supported_by:
- reference_id: PMID:8276399
supporting_text: "one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids"
# --- butyrate catabolic process (IBA) ---
- term:
id: GO:0046359
label: butyrate catabolic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: >-
Phylogenetically inferred butyrate (butanoate) catabolic process. ACADS acts on butyryl-CoA
(butanoyl-CoA) as its optimum substrate, dehydrogenating it to crotonyl-CoA, i.e. the
committed catabolic step for the C4 short-chain acyl-CoA. This is a substrate-specific framing
of the same beta-oxidation step that ACADS catalyzes.
action: KEEP_AS_NON_CORE
reason: >-
The annotation is reasonable given butyryl-CoA is the optimal substrate, but it is a narrow
substrate-specific restatement of the core short-chain fatty acid beta-oxidation role rather
than an independent biological process. Retained as non-core.
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
# --- acyl-CoA dehydrogenase activity (IEA, ARBA) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation (ARBA/InterPro) to the parent acyl-CoA dehydrogenase activity term.
Correct but less specific than the short-chain term (GO:0016937); ACADS is the dedicated
short-chain family member.
action: KEEP_AS_NON_CORE
reason: >-
The broad parent term is accurate but subsumed by the more specific short-chain ACAD activity
annotation, which better reflects ACADS substrate specificity.
supported_by:
- reference_id: PMID:3597357
supporting_text: "Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)"
# --- mitochondrion (IEA, ARBA) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: located_in
review:
summary: >-
Electronic (ARBA) annotation to mitochondrion. Correct; ACADS is a mitochondrial matrix
protein. Less specific than the matrix annotations also present.
action: KEEP_AS_NON_CORE
reason: >-
Mitochondrial localization is well established experimentally; this IEA term is consistent
with all evidence, though the matrix term is preferred for the core location.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"
# --- mitochondrial matrix (IEA, SubCell) ---
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Electronic annotation from UniProt Subcellular Location mapping. ACADS is a soluble
mitochondrial matrix enzyme; this is the correct, specific compartment.
action: ACCEPT
reason: >-
UniProt records the subcellular location as mitochondrion matrix (ECO:0000250|UniProtKB:Q3ZBF6),
consistent with ACADS being a soluble matrix beta-oxidation enzyme. This is the preferred
core localization.
# --- oxidoreductase activity, acting on the CH-CH group of donors (IEA, InterPro) ---
- term:
id: GO:0016627
label: oxidoreductase activity, acting on the CH-CH group of donors
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-derived electronic annotation to an intermediate oxidoreductase term. The
acyl-CoA dehydrogenase reaction is an oxidation of the alpha,beta (C2-C3) CH-CH bond,
so this parent term is accurate.
action: KEEP_AS_NON_CORE
reason: >-
Correct intermediate-level term between general oxidoreductase and the specific short-chain
ACAD activity; subsumed by the more specific MF annotation.
supported_by:
- reference_id: PMID:3597357
supporting_text: "Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)"
# --- short-chain fatty acyl-CoA dehydrogenase activity (IEA, Rhea/EC) ---
- term:
id: GO:0016937
label: short-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: >-
Electronic annotation from Rhea/EC (RHEA:24004 butanoyl-CoA, RHEA:43456, RHEA:47196;
EC 1.3.8.1) mapping to the short-chain ACAD activity term. Correct and concordant with
the curated catalytic activity in UniProt and the EXP annotation.
action: ACCEPT
reason: >-
Reflects the UniProt-curated EC 1.3.8.1 and Rhea reactions for short-chain acyl-CoA
dehydrogenation. This is the core molecular function.
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
# --- fatty acid beta-oxidation using acyl-CoA dehydrogenase (IEA, ARBA) ---
- term:
id: GO:0033539
label: fatty acid beta-oxidation using acyl-CoA dehydrogenase
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: >-
Electronic (ARBA) annotation duplicating the IBA process annotation. Correct and appropriately
specific for ACADS, which catalyzes the ACAD step of beta-oxidation.
action: ACCEPT
reason: >-
Consistent with the experimentally and phylogenetically supported role of ACADS in the
acyl-CoA dehydrogenase step of fatty acid beta-oxidation.
supported_by:
- reference_id: PMID:8276399
supporting_text: "one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids"
# --- flavin adenine dinucleotide binding (IEA, InterPro) ---
- term:
id: GO:0050660
label: flavin adenine dinucleotide binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-derived FAD binding annotation. ACADS is a flavoprotein binding one FAD per subunit
(UniProt cofactor; crystal structure 2VIG). FAD is essential for the dehydrogenase reaction.
Well-supported and correct.
action: ACCEPT
reason: >-
FAD binding is experimentally documented for purified human SCAD (1 mol FAD per subunit) and
structurally confirmed; this is a genuine and functionally important molecular function.
supported_by:
- reference_id: PMID:3597357
supporting_text: "each contains 1 mol of FAD per subunit"
# --- medium-chain fatty acyl-CoA dehydrogenase activity (IEA, Rhea) ---
- term:
id: GO:0070991
label: medium-chain fatty acyl-CoA dehydrogenase activity
evidence_type: IEA
original_reference_id: GO_REF:0000116
qualifier: enables
review:
summary: >-
Electronic Rhea-based annotation derived from RHEA:43464 (hexanoyl-CoA, C6). ACADS does
dehydrogenate hexanoyl-CoA (C6), which UniProt records as a curated catalytic activity
(ECO:0000269|PubMed:21237683); C6 sits at the boundary between short- and medium-chain.
However, the defining specificity of ACADS is short-chain (optimum butyryl-CoA, C4), and
dedicated MCAD (ACADM) handles medium-chain substrates in vivo.
action: KEEP_AS_NON_CORE
reason: >-
The C6 (hexanoyl-CoA) activity is real and machine-derived from a genuine UniProt-curated Rhea
reaction, so it should not be removed; but it represents the upper boundary of ACADS substrate
range rather than its core function. Retained as non-core.
supported_by:
- reference_id: PMID:3597357
supporting_text: "Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)"
# --- protein binding (IPI, BioPlex 28514442) ---
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
IPI annotation from the BioPlex 2.0 high-throughput affinity-purification interactome
(WITH UniProtKB:P16444, DPEP1). The generic 'protein binding' term is uninformative and
the reported partner (DPEP1, a membrane dipeptidase) has no established functional
relationship to short-chain fatty acid oxidation; the interaction is from a proteome-scale
AP-MS screen rather than a focused study.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Per curation guidelines, bare 'protein binding' should not be endorsed as it conveys no
functional information, and this high-throughput interaction is not corroborated by a
biologically meaningful partnership. Not a core function.
supported_by:
- reference_id: PMID:28514442
supporting_text: "robust affinity purification-mass spectrometry methodology to elucidate protein interaction networks"
# --- protein binding (IPI, BioPlex 33961781) ---
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
IPI annotation from the BioPlex 3.0 high-throughput interactome (WITH UniProtKB:P16444,
DPEP1). As above, 'protein binding' is uninformative and the partner derives from a
proteome-scale AP-MS dataset without focused functional follow-up for ACADS.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Generic protein binding from a high-throughput screen does not inform ACADS function and is
not a core annotation; retained but flagged as over-annotated.
supported_by:
- reference_id: PMID:33961781
supporting_text: "Through affinity-purification mass spectrometry, we have created two proteome-scale, cell-line-specific interaction networks"
# --- mitochondrion (IDA, HPA) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: >-
IDA annotation from HPA immunofluorescence. ACADS mitochondrial localization is confirmed
by immunofluorescence and consistent with all other evidence (matrix enzyme).
action: KEEP_AS_NON_CORE
reason: >-
Direct immunofluorescence localization to mitochondria is concordant with the matrix
localization established by UniProt, Reactome, and the MitoCoP proteome; the more specific
mitochondrial matrix term is the preferred core location.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"
# --- mitochondrial matrix (ISS) ---
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: located_in
review:
summary: >-
ISS annotation transferring matrix localization from the bovine ortholog (UniProtKB:Q3ZBF6).
ACADS is a soluble matrix beta-oxidation enzyme; this is the correct, specific compartment.
action: ACCEPT
reason: >-
Matrix localization is the documented UniProt subcellular location and is the appropriate
core compartment for this soluble matrix flavoenzyme.
# --- short-chain fatty acyl-CoA dehydrogenase activity (EXP, 21237683) ---
- term:
id: GO:0016937
label: short-chain fatty acyl-CoA dehydrogenase activity
evidence_type: EXP
original_reference_id: PMID:21237683
qualifier: enables
review:
summary: >-
Experimental (EXP) annotation. He et al. 2011 characterized the acyl-CoA dehydrogenase family
including substrate specificity work that underlies the EC 1.3.8.1 assignment and the curated
short-chain (C4-C6) substrate range for ACADS in UniProt (ECO:0000269|PubMed:21237683). The
cached abstract foregrounds the paralogs ACAD9/ACAD10/ACAD11, but the full text and UniProt
curation establish ACADS short-chain activity; this is the precise, correct MF term.
action: ACCEPT
reason: >-
UniProt cites PubMed:21237683 with experimental evidence (ECO:0000269) for ACADS function,
catalytic activity, and EC 1.3.8.1, and the curator read the full text. This is the core
molecular function and should not be removed because the abstract emphasizes paralogs.
supported_by:
- reference_id: PMID:21237683
supporting_text: "the acyl-CoA dehydrogenases (ACADs) participate in consecutive cycles of"
# --- mitochondrion (HTP, 34800366) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: HTP
original_reference_id: PMID:34800366
qualifier: located_in
review:
summary: >-
HTP annotation from the MitoCoP high-confidence human mitochondrial proteome (Morgenstern
et al. 2021). ACADS is identified as a high-confidence mitochondrial protein, consistent
with all targeted evidence.
action: KEEP_AS_NON_CORE
reason: >-
A rigorous, multi-dimensional mitochondrial proteomics study confirms ACADS mitochondrial
localization, reinforcing the matrix localization established by other methods; the more
specific mitochondrial matrix term is the preferred core location.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"
# --- acyl-CoA dehydrogenase activity (ISS) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
ISS annotation transferring acyl-CoA dehydrogenase activity from the bovine ortholog. Correct
parent term; the short-chain child term (GO:0016937) better reflects ACADS specificity.
action: KEEP_AS_NON_CORE
reason: >-
Accurate but broad; subsumed by the specific short-chain ACAD activity annotation.
supported_by:
- reference_id: PMID:3597357
supporting_text: "Short chain acyl-CoA (SCA), medium chain acyl-CoA (MCA), and isovaleryl-CoA (IV)"
# --- acyl-CoA dehydrogenase activity (IMP, 11134486) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: IMP
original_reference_id: PMID:11134486
qualifier: enables
review:
summary: >-
IMP annotation based on functional characterization of ACADS variants. Corydon et al. showed
that disease and susceptibility variants reduce or abolish SCAD activity, supporting that the
protein enables acyl-CoA dehydrogenase activity. Correct, though the short-chain term is more
specific.
action: KEEP_AS_NON_CORE
reason: >-
Variant studies directly demonstrate ACADS acyl-CoA dehydrogenase activity (e.g. variants with
reduced/abolished activity). The parent term is correct but subsumed by the specific
short-chain ACAD activity (GO:0016937); retained as non-core for consistency.
supported_by:
- reference_id: PMID:11134486
supporting_text: "functional SCAD deficiency due to the presence of susceptibility SCAD gene variations, i.e. 625G>A and 511C>T"
# --- short-chain fatty acyl-CoA dehydrogenase activity (ISS) ---
- term:
id: GO:0016937
label: short-chain fatty acyl-CoA dehydrogenase activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
qualifier: enables
review:
summary: >-
ISS annotation transferring the specific short-chain ACAD activity from the bovine ortholog.
Concordant with the EXP, IBA and IEA evidence; correct core molecular function.
action: ACCEPT
reason: >-
Specific and accurate MF term, supported by orthology and direct experimental data.
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
# --- acyl-CoA dehydrogenase activity (IDA, 3597357) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: IDA
original_reference_id: PMID:3597357
qualifier: enables
review:
summary: >-
IDA annotation from Finocchiaro et al. 1987, who purified human liver short-chain acyl-CoA
dehydrogenase to homogeneity and demonstrated dehydrogenation of butyryl-CoA to crotonyl-CoA,
a homotetrameric structure, and 1 mol FAD per subunit with ETF as electron acceptor. This is
direct biochemical evidence for ACADS enzymatic activity.
action: KEEP_AS_NON_CORE
reason: >-
The foundational purification/enzymology study directly establishes ACADS acyl-CoA
dehydrogenase activity. The parent term is correct but is subsumed by the more specific
short-chain ACAD activity (GO:0016937), so it is retained as non-core for consistency.
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
- reference_id: PMID:3597357
supporting_text: "indicating a homotetrameric structure"
# --- fatty acid beta-oxidation using acyl-CoA dehydrogenase (IDA, 3597357) ---
- term:
id: GO:0033539
label: fatty acid beta-oxidation using acyl-CoA dehydrogenase
evidence_type: IDA
original_reference_id: PMID:3597357
qualifier: involved_in
review:
summary: >-
IDA annotation from Finocchiaro et al. 1987. Purified human SCAD catalyzes the acyl-CoA
dehydrogenase step of beta-oxidation (butyryl-CoA to crotonyl-CoA), directly supporting
involvement in this process.
action: ACCEPT
reason: >-
Direct demonstration that ACADS catalyzes the ACAD step of fatty acid beta-oxidation. This is
the core biological process for ACADS.
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
# --- nucleus (HDA, 21630459) ---
- term:
id: GO:0005634
label: nucleus
evidence_type: HDA
original_reference_id: PMID:21630459
qualifier: located_in
review:
summary: >-
HDA annotation from a human sperm-nucleus proteomics dataset (de Mateo et al. 2011). ACADS is
a soluble mitochondrial matrix flavoenzyme with a cleaved mitochondrial transit peptide and no
known nuclear role; its detection in a large sperm-nucleus proteome is best explained by
mitochondrial/cytoplasmic carryover rather than genuine nuclear localization.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The nuclear localization is unsupported by ACADS biology (matrix beta-oxidation enzyme) and
derives from a high-throughput proteomics dataset prone to contamination. It does not reflect
a real subcellular function and is flagged as over-annotated rather than core.
supported_by:
- reference_id: PMID:21630459
supporting_text: "403 different proteins have been identified from the isolated sperm nuclei"
# --- mitochondrial matrix (TAS, Reactome 77319) ---
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77319
qualifier: located_in
review:
summary: >-
TAS annotation from the Reactome reaction "Butanoyl-CoA+FAD => Crotonoyl-CoA+FADH2", placing
ACADS in the mitochondrial matrix where it catalyzes butyryl-CoA dehydrogenation. Correct
compartment for this matrix enzyme.
action: ACCEPT
reason: >-
Reactome correctly localizes the ACADS-catalyzed short-chain beta-oxidation step to the
mitochondrial matrix, concordant with UniProt and proteomics evidence.
# --- mitochondrial matrix (TAS, Reactome 77327) ---
- term:
id: GO:0005759
label: mitochondrial matrix
evidence_type: TAS
original_reference_id: Reactome:R-HSA-77327
qualifier: located_in
review:
summary: >-
TAS annotation from the Reactome reaction "Hexanoyl-CoA+FAD => trans-Hex-2-enoyl-CoA+FADH2",
placing ACADS in the mitochondrial matrix for the C6 dehydrogenation step. Correct compartment.
action: ACCEPT
reason: >-
Concordant with the documented matrix localization of this soluble beta-oxidation enzyme.
# --- mitochondrion (IDA, MGI 16729965) ---
- term:
id: GO:0005739
label: mitochondrion
evidence_type: IDA
original_reference_id: PMID:16729965
qualifier: located_in
review:
summary: >-
IDA annotation curated by MGI and associated with PMID:16729965 (a study primarily about
OCTN1/SLC22A4 localization to mitochondria). The cached record is abstract-only and concerns
a different gene, but mitochondrial localization for ACADS is unambiguous from multiple
independent lines of evidence, so the localization assigned here is correct.
action: KEEP_AS_NON_CORE
reason: >-
Mitochondrial localization of ACADS is firmly established (UniProt matrix, Reactome, HPA,
MitoCoP). Per guidance, an experimental localization annotation whose full text we cannot
read should not be overruled, and the assigned compartment is independently confirmed; the
more specific mitochondrial matrix term is the preferred core location.
supported_by:
- reference_id: PMID:34800366
supporting_text: "Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context"
# --- acyl-CoA dehydrogenase activity (TAS, 2565344) ---
- term:
id: GO:0003995
label: acyl-CoA dehydrogenase activity
evidence_type: TAS
original_reference_id: PMID:2565344
qualifier: enables
review:
summary: >-
TAS annotation from the human SCAD cDNA cloning paper (Naito et al. 1989), which identified
the gene as encoding short-chain acyl-CoA dehydrogenase. Correct molecular function at the
parent level; the specific short-chain term is preferred.
action: KEEP_AS_NON_CORE
reason: >-
The cloning paper establishes the identity of ACADS as an acyl-CoA dehydrogenase. Accurate but
broad; subsumed by the specific short-chain ACAD activity annotation, so retained as non-core
for consistency.
supported_by:
- reference_id: PMID:2565344
supporting_text: "Complementary DNAs encoding the precursor of human placental short chain"
# --- fatty acid beta-oxidation (TAS, 8276399) ---
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: TAS
original_reference_id: PMID:8276399
qualifier: involved_in
review:
summary: >-
TAS annotation from the mouse SCAD cDNA paper (Kelly et al. 1993), which states SCAD is one
of the homologous dehydrogenases catalyzing the first reaction of fatty acid beta-oxidation
and acts on short-chain (C4-C6) acyl-CoA. Correct biological process for ACADS.
action: ACCEPT
reason: >-
The (ortholog) cloning paper accurately describes SCAD's role in the first step of fatty acid
beta-oxidation, a core biological process for ACADS.
supported_by:
- reference_id: PMID:8276399
supporting_text: "one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids"
# --- fatty acid beta-oxidation (IC, 11134486) ---
- term:
id: GO:0006635
label: fatty acid beta-oxidation
evidence_type: IC
original_reference_id: PMID:11134486
qualifier: involved_in
review:
summary: >-
IC (inferred by curator) annotation deriving the fatty acid beta-oxidation process from the
ACADS acyl-CoA dehydrogenase molecular function (WITH GO:0003995), based on Corydon et al.
2001. SCAD deficiency is an inborn error of mitochondrial fatty acid oxidation, consistent
with this process annotation.
action: ACCEPT
reason: >-
Curator inference from the demonstrated MF to the beta-oxidation process is well-justified;
ACADS is integral to short-chain fatty acid beta-oxidation, and its deficiency is a FAO
disorder. This is a core biological process.
supported_by:
- reference_id: PMID:11134486
supporting_text: "Short-chain acyl-CoA dehydrogenase (SCAD) deficiency is considered a rare inherited mitochondrial fatty acid oxidation disorder"
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000116
title: Automatic Gene Ontology annotation based on Rhea mapping
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:11134486
title: Role of common gene variations in the molecular pathogenesis of short-chain
acyl-CoA dehydrogenase deficiency.
findings:
- statement: >-
SCAD deficiency is an inherited mitochondrial fatty acid oxidation disorder; common
susceptibility variants 625G>A and 511C>T cause functional SCAD deficiency and predispose
to ethylmalonic aciduria.
supporting_text: >-
functional SCAD deficiency due to the presence of susceptibility SCAD gene variations, i.e.
625G>A and 511C>T
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
PubMed-verified. Underlies the IMP MF (GO:0003995), IC BP (GO:0006635), and UniProt FUNCTION
and disease annotations for ACADS. Abstract-only in cache.
- id: PMID:16729965
title: Novel localization of OCTN1, an organic cation/carnitine transporter, to
mammalian mitochondria.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Abstract is about OCTN1/SLC22A4 mitochondrial localization, not ACADS. MGI used this work to
assign an IDA mitochondrion annotation to ACADS (likely as a mitochondrial marker in the
study); full text unavailable here. The localization itself is independently correct, so the
annotation was accepted rather than challenged.
- id: PMID:21237683
title: Identification and characterization of new long chain acyl-CoA dehydrogenases.
findings:
- statement: >-
Acyl-CoA dehydrogenases participate in consecutive cycles of beta-oxidation to generate
acetyl-CoA and reducing equivalents; the paper characterizes ACAD family members and
underlies the curated short-chain substrate specificity for ACADS.
supporting_text: >-
the acyl-CoA dehydrogenases (ACADs) participate in consecutive cycles of
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
UniProt cites this with experimental evidence (ECO:0000269) for ACADS FUNCTION, catalytic
activity, and EC 1.3.8.1. Abstract foregrounds ACAD9/10/11 paralogs, but the full text and
UniProt curation support ACADS short-chain activity; the EXP annotation was retained.
- id: PMID:21630459
title: Proteomic characterization of the human sperm nucleus.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large sperm-nucleus proteomics dataset that is the basis for a spurious nucleus annotation
on ACADS (a mitochondrial matrix enzyme). Most consistent with contamination/carryover;
annotation marked over-annotated.
- id: PMID:2565344
title: Molecular cloning and nucleotide sequence of complementary DNAs encoding
human short chain acyl-coenzyme A dehydrogenase and the study of the molecular
basis of human short chain acyl-coenzyme A dehydrogenase deficiency.
findings:
- statement: >-
Cloned and sequenced cDNA encoding the 412-aa precursor of human short-chain acyl-CoA
dehydrogenase (SCAD), with a 24-aa leader and 388-aa mature protein, related to MCAD.
supporting_text: >-
Complementary DNAs encoding the precursor of human placental short chain
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Foundational cloning paper establishing the identity of ACADS; basis for TAS MF annotation.
- id: PMID:34800366
title: Quantitative high-confidence human mitochondrial proteome and its dynamics
in cellular context.
findings:
- statement: >-
ACADS is a member of the high-confidence human mitochondrial proteome (MitoCoP).
supporting_text: >-
Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular
context
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Rigorous mitochondrial proteomics supporting ACADS mitochondrial localization (HTP).
- id: PMID:3597357
title: Purification and properties of short chain acyl-CoA, medium chain acyl-CoA,
and isovaleryl-CoA dehydrogenases from human liver.
findings:
- statement: >-
Human liver SCAD was purified to homogeneity; it is a homotetramer with 1 mol FAD per
subunit, uses ETF as electron acceptor, and converts butyryl-CoA to crotonyl-CoA.
supporting_text: >-
The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV
dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Definitive biochemical characterization of human SCAD; basis for IDA MF/BP annotations and
core enzymology (homotetramer, FAD, ETF, butyryl-CoA -> crotonyl-CoA).
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex 2.0 high-throughput AP-MS interactome; basis for an uninformative 'protein binding'
annotation (WITH DPEP1). Marked over-annotated.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
BioPlex 3.0 high-throughput AP-MS interactome; basis for an uninformative 'protein binding'
annotation (WITH DPEP1). Marked over-annotated.
- id: PMID:8276399
title: Cloning and characterization of the mouse short-chain acyl-CoA dehydrogenase
cDNA.
findings:
- statement: >-
SCAD is one of the homologous dehydrogenases catalyzing the first reaction of fatty acid
beta-oxidation, with short-chain (C4-C6) acyl-CoA substrates.
supporting_text: >-
one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation
of fatty acids
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: >-
Mouse ortholog cloning paper; clearly states the SCAD role in the first step of beta-oxidation
and short-chain substrate specificity. Basis for TAS BP annotation.
- id: Reactome:R-HSA-77319
title: Butanoyl-CoA+FAD => Crotonoyl-CoA+FADH2
findings: []
- id: Reactome:R-HSA-77327
title: Hexanoyl-CoA+FAD => trans-Hex-2-enoyl-CoA+FADH2
findings: []
core_functions:
- description: >-
ACADS catalyzes the first, FAD-dependent step of mitochondrial fatty acid beta-oxidation for
short-chain substrates: the alpha,beta-dehydrogenation of saturated short-chain (C4-C6)
acyl-CoA thioesters to the corresponding trans-2-enoyl-CoA (optimum substrate butyryl-CoA),
transferring electrons to electron-transfer flavoprotein (ETF). It acts as a soluble
homotetramer in the mitochondrial matrix with one FAD per subunit.
molecular_function:
id: GO:0016937
label: short-chain fatty acyl-CoA dehydrogenase activity
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
- id: GO:0033539
label: fatty acid beta-oxidation using acyl-CoA dehydrogenase
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:3597357
supporting_text: "The products of SCA dehydrogenase/butyryl-CoA, MCA dehydrogenase/octanoyl-CoA, and IV dehydrogenase/isovaleryl-CoA reactions were identified as crotonyl-CoA"
- reference_id: PMID:3597357
supporting_text: "each contains 1 mol of FAD per subunit"
- reference_id: PMID:8276399
supporting_text: "one of five homologous dehydrogenases that catalyze the first reaction in the beta-oxidation of fatty acids"
- description: >-
Cofactor binding required for catalysis. Each SCAD subunit binds one non-covalently associated
FAD, the redox cofactor that accepts the two electrons removed from the short-chain acyl-CoA
substrate before passing them to electron-transfer flavoprotein (ETF); FAD is essential for
dehydrogenase activity.
molecular_function:
id: GO:0050660
label: flavin adenine dinucleotide binding
directly_involved_in:
- id: GO:0006635
label: fatty acid beta-oxidation
locations:
- id: GO:0005759
label: mitochondrial matrix
supported_by:
- reference_id: PMID:3597357
supporting_text: "each contains 1 mol of FAD per subunit"
proposed_new_terms: []
suggested_questions:
- question: >-
What accounts for the wide variability in clinical severity of ACADS deficiency, given that
common susceptibility variants (625G>A, 511C>T) are frequent in the general population and many
individuals with ethylmalonic aciduria are asymptomatic?
- question: >-
Beyond energy-yielding short-chain fatty acid beta-oxidation, does ACADS contribute to the
catabolism of specific short-chain acyl-CoA pools (e.g. butyryl-CoA derived from amino acid or
microbial-derived butyrate metabolism) in particular tissues?
suggested_experiments:
- description: >-
Quantitative measurement of short-chain acyl-CoA flux (C4-C6) in tissues or cell models with
defined ACADS genotypes (including the common 625G>A and 511C>T variants) to define the
genotype-to-biochemical-phenotype relationship and the functional threshold for ethylmalonic
aciduria.
- description: >-
Structure-guided enzyme kinetics across the C4-C8 acyl-CoA range using purified recombinant
human SCAD to precisely delimit the short-chain specificity boundary (especially the extent of
C6/hexanoyl-CoA activity) relative to MCAD, clarifying the medium-chain annotation.